ARCA biopharma, Inc. (ABIO)
Company Info
ISIN | US00211Y5069 |
---|---|
CUSIP | 00211Y506 |
Sector | Healthcare |
Industry | Biotechnology |
Highlights
Market Cap | $24.58M |
---|---|
EPS | -$0.37 |
EBITDA (TTM) | -$7.12M |
Year Range | $1.56 - $2.16 |
Target Price | $7.00 |
Short % | 1.76% |
Short Ratio | 7.37 |
Share Price Chart
Loading data...
Compare to other instruments
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in ARCA biopharma, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
ARCA biopharma, Inc. had a return of 1.18% year-to-date (YTD) and -19.63% in the last 12 months. Over the past 10 years, ARCA biopharma, Inc. had an annualized return of -39.43%, while the S&P 500 had an annualized return of 10.71%, indicating that ARCA biopharma, Inc. did not perform as well as the benchmark.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | 1.18% | 7.96% |
1 month | 2.99% | 2.87% |
6 months | -16.50% | 15.63% |
1 year | -19.63% | 31.48% |
5 years (annualized) | -25.68% | 12.80% |
10 years (annualized) | -39.43% | 10.71% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | -6.47% | 3.77% | ||||||||||
2023 | 0.49% | -1.95% | -10.95% | 1.68% | -6.59% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
This table presents risk-adjusted performance metrics for ARCA biopharma, Inc. (ABIO) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
---|---|---|---|---|---|
ARCA biopharma, Inc. | -0.85 | ||||
S&P 500 | 2.54 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the ARCA biopharma, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the ARCA biopharma, Inc. was 100.00%, occurring on Feb 1, 2024. The portfolio has not yet recovered.
The current ARCA biopharma, Inc. drawdown is 100.00%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-100% | Nov 16, 2000 | 5837 | Feb 1, 2024 | — | — | — |
-87.35% | Sep 29, 1997 | 385 | Apr 9, 1999 | 190 | Jan 7, 2000 | 575 |
-14.06% | Aug 12, 1997 | 6 | Aug 19, 1997 | 14 | Sep 9, 1997 | 20 |
-7.58% | May 26, 2000 | 1 | May 26, 2000 | 1 | May 30, 2000 | 2 |
-4.74% | Apr 17, 2000 | 1 | Apr 17, 2000 | 1 | Apr 18, 2000 | 2 |
Volatility
Volatility Chart
The current ARCA biopharma, Inc. volatility is 5.50%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Income Statement
TTM | 2023 | 2022 | 2021 | 2020 | |
---|---|---|---|---|---|
Revenue | |||||
Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Revenue | 111.00K | 111.00K | 114.00K | 91.00K | 93.00K |
Gross Profit | -111.00K | -111.00K | -114.00K | -91.00K | -93.00K |
Operating Expenses | |||||
Selling, General & Admin Expenses | 6.28M | 6.28M | 5.85M | 5.50M | 4.77M |
R&D Expenses | 1.01M | 1.01M | 4.75M | 13.83M | 4.99M |
Total Operating Expenses | 7.30M | 7.30M | 10.60M | 19.34M | 9.77M |
Income | |||||
Income Before Tax | -5.34M | -5.34M | -9.93M | -19.32M | -9.75M |
Operating Income | -7.30M | -7.30M | -10.60M | -19.34M | -9.77M |
EBIT | -7.36M | -7.30M | -10.60M | -19.34M | -9.77M |
Earnings From Continuing Operations | -5.34M | -5.42M | -9.93M | -19.32M | -9.74M |
Net Income | -4.37M | -5.34M | -9.26M | -19.23M | -9.74M |
Income Tax Expense | -1.00M | -111.00K | -670.00K | -91.00K | -9.00K |
Interest Expense | -450.00K | 0.00 | 675.00K | 13.00K | 9.00K |
Other Non-Operating Income (Expenses) | 1.96M | 1.96M | 670.00K | 13.00K | 19.00K |
Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Effect Of Accounting Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Recurring | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |